“Lithium toxicity”的搜索结果，显示 31-40 项，共有 7183 项

1. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

2. 铅中毒- 症状与病因- 妙佑医疗国际

   Lead poisoning: An update. Pediatrics in Review. 2021; doi:10.1542/pir.2020-0026. Lead poisoning. World Health Organization. https://www.who.int/news ...

3. 放射科- 临床试验- 妙佑医疗国际

   A Study Of Clonal Hematopoiesis (CH) And Hematological Toxicity After Cancer Treatment. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The ...

4. 放射科- 临床试验- 妙佑医疗国际

   A Study Of Clonal Hematopoiesis (CH) And Hematological Toxicity After Cancer Treatment. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Is [Ac225]RTX-2358 tolerable or does it cause toxicities (medical problems) in patients. What is the most tolerable dose of [Ac225]RTX-2358. Does the treatment ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

7. 神经科- 临床试验- 妙佑医疗国际

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   TTF represents a new modality that is well tolerated with minimal adverse events. TTF has not produced significant additive toxicity when combined with systemic ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...